PA
MED icon

Parallel Advisors’s Medifast MED Stock Holding History

Parallel Advisors’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-50
Closed -$684 – 3704
2025
Q3 		$684 Hold
50
– – ﹤0.01% 3292
2025
Q2 		$703 Buy
+50
New +$657 ﹤0.01% 3261
2024
Q4 		– Sell
-30
Closed -$574 – 3582
2024
Q3 		$574 Buy
+30
New +$578 ﹤0.01% 3160
2024
Q1 		– Sell
-321
Closed -$21.6K – 3379
2023
Q4 		$21.6K Buy
321
+1
+0.3% +$70 ﹤0.01% 1891
2023
Q3 		$24K Sell
320
-109
-25% -$9.67K ﹤0.01% 1745
2023
Q2 		$39.5K Buy
429
+181
+73% +$16.1K ﹤0.01% 1523
2023
Q1 		$25.7K Buy
248
+76
+44% +$8.42K ﹤0.01% 1711
2022
Q4 		$19.8K Buy
172
+150
+682% +$17.5K ﹤0.01% 1714
2022
Q3 		$2K Buy
22
+21
+2,100% +$3.01K ﹤0.01% 2688
2022
Q2 		$0 Buy
+1
New +$179 ﹤0.01% 3210
2021
Q4 		– Sell
-20
Closed -$4K – 3204
2021
Q3 		$4K Hold
20
– – ﹤0.01% 2472
2021
Q2 		$6K Sell
20
-12
-38% -$3.25K ﹤0.01% 2236
2021
Q1 		$7K Buy
32
+12
+60% +$2.87K ﹤0.01% 2070
2020
Q4 		$4K Buy
+20
New +$3.53K ﹤0.01% 2114
2020
Q3 		– Sell
-3,705
Closed -$514K – 2635
2020
Q2 		$514K Buy
+3,705
New +$340K 0.03% 287
2019
Q4 		– Sell
-27
Closed -$3K – 2458
2019
Q3 		$3K Sell
27
-59
-69% -$6.34K ﹤0.01% 2074
2019
Q2 		$11K Hold
86
– – ﹤0.01% 1553
2019
Q1 		$11K Buy
86
+59
+219% +$7.48K ﹤0.01% 1492
2018
Q4 		$3K Hold
27
– – ﹤0.01% 1756
2018
Q3 		$6K Hold
27
– – ﹤0.01% 1658
2018
Q2 		$4K Buy
+27
New +$3.45K ﹤0.01% 1676
2017
Q2 		– Sell
-25
Closed -$1K – 2163
2017
Q1 		$1K Buy
+25
New +$1.08K ﹤0.01% 1897

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Parallel Advisors's MED Position: Q4 2025 in Review

Parallel Advisors sold out of Medifast (MED) in Q4 2025, closing a stake of 50 shares — an estimated $684 sold.

Parallel Advisors first reported a position in MED in Q1 2017 and held it in 22 quarters. The position peaked at $514K in Q2 2020. 109 funds tracked by Wall St. Rank hold MED as of Q4 2025.

  • Parallel Advisors reported no remaining Medifast position as of Q4 2025 after selling out during the quarter.
  • Parallel Advisors sold 50 Medifast shares in Q4 2025, an estimated $684.
  • Parallel Advisors first reported a position in Medifast in Q1 2017 and held it in 22 quarters.
  • Parallel Advisors's Medifast position peaked at $514K in Q2 2020.
  • 109 funds tracked by Wall St. Rank held Medifast as of Q4 2025.

Based on Parallel Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.